Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the link yesterday for Run From The Cure.
That was simply unbelievable
I understand your concerns I have some as well. I tend to look at it like this. If CBIS puts themselves in a position to treat patients and has sucessful outcomes those shrares or loans are worth their weight in gold as it will be more concrete evidence to bring to the FDA. Of course that is a chance someone has to be willing to take when they invest in this stock. If you believe foward looking events are positive then probably buy. If not then swing trade or flip however you like. whatever you decide is up to you. For me I am trying to accumulate as much as I can as I believe foward looking events will have a great positive effect on the co. and pps. Good luck to you
You will see a better bang for the buck when the deal is finalized. Cbis is trying to be as transparant as possible with everyone and i think they have been doing a great job of that. So in answer to your question as to why we didn't do better than 8% on that news imo is because it still needs to be finalized.What do you think the pps will be at if that deal gets done and they are treating people within 1 or 2 months of the deal finalizing. I am just curious that's all.
i didn't know Dr. Melamede was a foundation member did you?
http://www.phoenixtearsfoundation.com/foundation-members/
now this is someone other than CBIS saying CBIS is killing cancer
from phoenix tears foundation website. nice mention of our good Dr. Melamede
These studies provide the scientific foundation that supports the anecdotal results of individuals self-administering cannabis extracts. These anecdotal reports include outright cures or significantly controlling diseases like cancer, diabetes, heart disease, arthritis, Crohn’s disease, chronic pain, fibromyalgia, hepatitis C, and more. Everything that people report cannabis extracts to be effective for has scientific study backing it up, as well as the fact that multiple people are reporting the same results. In addition, doctors like Dr. Robert Melamede and Dr. William Courtney have had success in treating cancer and lupus with cannabis extracts, or in Dr. Courtney’s case, raw juiced cannabis. It is undeniable that cannabis is the best medicine humanity has its disposal, and the purpose of this Foundation is to bring this issue forward and get it the attention it deserves. Under serious scientific scrutiny, the truth will prevail.
http://www.phoenixtearsfoundation.com/
last 10 min push to green? we'll see i hope so
OOFAHHHHHHH!!!!!!
i guess this will throw a little more into the asset column. love it
glad you held on now?
besides if this was going to be an extreme selloff based off the 10k we would be looking at another 100mil volume day. Don't see anywhere near that happening today. Relax everyone, we have support at .11 which has not been broken and also 200dms over .10 another support level which has not been broken since the start of the year.Take a breath and RELAX for a minute
Good morning Hector. What were you thoughts on the 10k. IMHO it was not that bad. I have seen tons of pennies at this stage in the billions a/s.I think CBIS is in a better position than most pennies at this stage.
ISN'T CANADA OUR 1ST MARKET.CHECK THIS OUT.SUPREME COURT RULES IN FAVOR OF MEDICAL CANNABIS IN ANY FORM
http://www.camcd-acdcm.ca/2012/04/medical-marijuana-bakery-trial-program-once-again-declared-unconstitutional/
agreed
Do we have to go over this again. Geesh I would expect someone who fought for our country and our rights...one of them being innocent until proven guilty.PROVE CBIS GUILTY......oh that's right you can't. You can only dribble...wait let me get you a napkin for that
well according to your prior post you were expecting it to be between 400-500 mil and you wouldn't be surprised if it was higher.so i guess CBIS is doing far better than you expect which is what they'll continue to do. I guess you need a better grasp of this company.those guestimates were just that pure spec and now per you confirmation it is nowhere near that.you really should be good at this by now...lol
now that's what i'm talkin about. i wish i had 100k shares. i've only been in since mid feb w/ver small investment but so far able to accumulate 10k. hoping to acc a lot more like you.
I wouldn't even get involved with him in ref to the biopsy. He stated a few days ago that he called CBIS and they said they refuse to publish it on the website. I asked for proof and there was none to be had. He did what he always does which is skirt around a direct question with other dribble
Goos morning all. Ready for another fun filled week? GLTA
and from this
Cannabis Science, Inc. : Cannabis Science Releases Second Cannabis-Extract-Based Formulation Available Now at Marisol Therapeutics, 922 Kimble Drive, Pueblo West, Colorado
11/23/2011 | 02:20pm
Cannabis Science, Inc. (OTCBB; CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the successful release of the second Cannabis Science brand formulation. The Company has been receiving a constant flow of inquires via its website, emails, and telephone calls for cannabis-extract based medicines. For example, cancer patients seeking extract-based formulations for topical or internal use have frequently contacted Cannabis Science. Manufacturing and packaging has been completed and is now available through Marisol Therapeutics for patient usage.
PHONE: 719-547-4000
ADDRESS: 922 Kimble Drive Pueblo West, CO 81007
EMAIL: INFO@MARISOLMED.COM
In light of the accumulating anecdotal reports of the successful cancer treatments with cannabis extracts, the Company will continue to keep patients updated on current peer-reviewed scientific literature supporting the historical and modern use of cannabis to treat "tumors". Unlike conventional treatment, cannabis medicines have an outstanding safety profile allowing patients in states with medical marijuana laws to safely make informed decisions to legally self-administration of various cannabis-based preparations.
The second Cannabis Science Brand extract-based formulation is comprised of high quality extract packaged in oral dispensing syringes for patient self-administration for treatment. This is a critical milestone for the Company in bringing its second formulation to market. Other formulations will be made available soon to medical marijuana patients in Colorado and around the world through the Company's vetted dispensaries. The Company's intent is to work with specially appointed legal providers and laboratories to expand the availability of its formulations across the United States and the world where legally available.
Dr. Melamede stated, "Cannabis Science is very proud with the release of this second cannabis extract based formulation. Discussions that are going on around the world in the scientific and medical communities as well as conversations with patients all point to a market need for these types of cannabis formulations. We look forward to future releases of more cannabis extract based formulations over the next year as we expand into California, and other States around the United States and the globe where medical cannabis is legal and can be accessed by the patients that need it most."
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science Inc.
Robert Kane, 1-561-234-6929
Investor Relations Management
or
Dr. Robert J. Melamede Ph.D., 1-888-889-0888
President & CEO
info@cannabisscience.com
www.cannabisscience.com
Revenues from this will show up on this 10k
Cannabis Science Releases First Cannabis-Extract-Based Formulation Available Now at Cannabis Therapeutics, 957 E. Fillmore St, Colorado Springs, Colorado
October 27, 2011
DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the successful release of the first Cannabis Science brand formulation. The Company has been receiving a constant flow of inquires via its website, emails, and telephone calls for cannabis-extract based medicines. For example, cancer patients seeking extract-based formulations for topical or internal use have frequently contacted Cannabis Science. Manufacturing and packaging has been completed and is now available through Cannabis Therapeutics for patient usage.
Cannabis Therapeutics
www.cannabistherapeutics.net
907 E Fillmore St.
Colorado Springs, CO 80907
(719) 633-7124
In light of the accumulating anecdotal reports of the successful cancer treatments with cannabis extracts, the Company will continue to keep patients updated on current peer-reviewed scientific literature supporting the historical and modern use of cannabis to treat "tumors”. Unlike conventional treatment, cannabis medicines have an outstanding safety profile allowing patients in states with medical marijuana laws to safely make informed decisions to legally self-administration of various cannabis-based preparations.
The first Cannabis Science Brand extract-based formulation is comprised of high quality oil packaged in oral dispensing syringes for patient self-administration for treatment. This is a critical milestone for the Company in bringing its first formulation to market. Other formulations will be made available soon to medical marijuana patients in Colorado through the Company’s vetted dispensaries. The Company’s intent is to work with specially appointed legal providers and laboratories to expand the availability of its formulations across the United States where legally available.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The first formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Contacts
Cannabis Science Inc.
Dr. Robert J. Melamede
President & CEO
1-888-889-0888
info@cannabisscience.com
www.cannabisscience.com
so there actually may be some good news on this 10k and not as horrile as some posters are making it seem it is so sure to be.
so could this mean that the company is actually making some REVENUE???????
I actualy think he ran from the board tonight. First time I have ever seen that happen. Keep up the great posts. i enjoy the valid information that you post.
There is no evidence to support anything he says. His only answer to any question posed to him is "wait for the 10k" He has no facts on anything, therefore he is null and void
Wow what is that like 4 reply posts and you still have not answered my initial question. How transparant can someone be.
That's what I thought. Let's make it even better. Show me where they told you they REFUSED to post the bioposy on their website and I will sell your every single one of my shares for .05 This way you can at least make some money.
Again....it's real simple. You said they REFUSED to post it on their website. I want to see how you came to that conclusion. You had to either call or email them and get a response. Credibility smashed. Goodbye Gomez
so i guess you called CBIS and they told you theyrefused to postthe biopsy as per your prior post. Where is your proof that that REFUSED to post it on their website. Get out
it's obvious there is no foward thinking out of him. I really hope you do this for pure entertainment. Cause I'm lovin it
Yeah awakened to $2.00/share hahahahahahaha
That's not really what I was asking about, but thanks for the response anyway
Thought I was going crazy thinking dilution was like the end of the world or something,but it seems like CBIS is being very responsible the way they are doing things. I guess we'll wait and see how good early next week. thanks
LMAO!!!!!!TOO FUNNY
Quick question about dilution. If CBIS did dilute let's say 50mil shares into the run to .24 and let's just say they got average of .15 then didn't they get 7.5 mil dollars. There was after all over 200 mil shares traded in 2 days then right. So I'm thinking that should cover quite a bit of what they have been doing lately.Am I correct to think this way?
thanks newmedman...can't wait to see how it's viewed. Hopefully lots of positives. As long as it's not too crazy with share structure i'll be happy.anyway i'm in long so i see ya on the boards. Have a great weekend
is the filing due 15 calendar days or 15 business days after the extension was filed?Is it for sure due by Sunday?
breaking up now .14's
Thanks...i think the SMA is what I have been seeing us bounce off of when we get close to it. If we hang here for another week or so i think we go a bit. Last time we came close went from .086 to over .17. Just something else to think about.all imho of course
ANYONE KNOW WHAT CURRENT 50DMA IS. I THINK IT'S ALMOST AT .10 BY NOW. SEEMS TO ME IF THAT CATCHES UP TO US OR GETS TO THAT .115 WE JUST SAW.....TIME FOR A NICE POP AS WE HAVEN'T BEEN BELOW 50DMA SINCE BEGINNING OF JAN. SEEMS LIKE CONSOLIDATION WHICH IS NICE IF WE HIT THAT AGAIN.IMHO